Preimplantation Genetic Testing in Women of Advanced Maternal Age

Not Applicable

Recruiting

• Conditions: Infertility, Female
• Interventions: Procedure: Preimplantation genetic testing for aneuploidy (PGT-A)

• Registration Number: NCT04167748
• Lead Sponsor: Genomic Prediction Inc.

Brief Summary

The GETSET trial is a prospective randomized trial designed to evaluate the clinical outcomes of incorporating preimplantation genetic testing for aneuploidies (PGT-A) in elective single embryo transfer in women between 35 and 40 years of age.

Detailed Description

In this randomized controlled trial, a total of 240 patients divided evenly across the two participating IVF centers will be recruited. Patients will be randomized to a control and to a treatment group, each containing 120 participants.

Only patients with at least one evaluable blastocyst will be randomized. Patients will undergo ovarian hyper-stimulation, oocyte retrieval, fertilization and embryo culture per standard clinical protocol determined by IVF center.

In the control arm, patients will undergo a single frozen embryo transfer with an untested blastocyst with the best morphology. All other blastocysts with lower morphology will undergo trophectoderm biopsy on day 5, 6 or 7 and will be frozen. PGT-A results of the untransferred embryos will be revealed to the patient AFTER the outcome of the initial ET is known. If the initial transfer results in a non-conception cycle and additional euploid embryos are available for transfer, these cycles will be followed and their outcomes collected.

In the experimental arm, all embryos will be cultured to blastocyst and all viable blastocysts will undergo trophectoderm biopsy and PGT-A. PGT-A will be performed regardless of the number of blastocysts available. Patients will undergo frozen transfer of the single, best quality euploid blastocyst. If the initial transfer results in a non-conception cycle and additional embryos are available for transfer, these cycles will be followed and their outcomes collected until the embryo cohort is exhausted.

Study Timeline

• Study First Submitted: 2019-11-15
• Study First Submitted QC: 2019-11-15
• Study First Posted: 2019-11-19
• Study Start: 2021-03-05
• Status Verified: 2023-11
• Last Update Submitted: 2023-11-16
• Last Update Posted: 2023-11-18
• Primary Completion: 2024-11-01
• Study Completion: 2024-12

Recruitment & Eligibility

• Status: RECRUITING
• Sex: Female
• Target Recruitment: 240

Inclusion Criteria

• Women undergoing IVF of between 35 and 40 years of age at IVF cycle start
• Utilization of Intracytoplasmic Sperm Injection ICSI
• Utilization of ejaculated or testicular sperm
• Utilization of autologous or donor sperm
• All Controlled Ovarian Hyperstimulation (COH) protocols

Exclusion criteria:

• Patients with anovulatory Polycystic ovarian syndrome (PCOS)
• Utilization of donor oocytes
• Utilization of gestational carrier
• Recurrent Pregnancy Loss (RPL) defined as ≥ 3 consecutive miscarriages
• Recurrent Implantation Failure (RIF) defined as ≥ 3 more failed embryo transfers

Exclusion Criteria

Not provided

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: PARALLEL

Arm && Interventions

Group	Intervention	Description
PGT-A transfer	Preimplantation genetic testing for aneuploidy (PGT-A)	Transfer of single chromosomally normal (euploid) blastocyst after PGT-A

Primary Outcome Measures

Name	Time	Method
Ongoing pregnancy rate	Up to 18 months	Number of patients who experience an ongoing pregnancy rate (\>20 weeks of gestation) after their first embryo transfer

Secondary Outcome Measures

Name	Time	Method
Miscarriage rate	Up to 18 months	Number of patients who experience a miscarriage after their first embryo transfer

Trial Locations

Locations (1)

IVF Florida Reproductive Associates; 🇺🇸 Margate, Florida, United States